test-nav-cat
Sep
22

HCC in Patients with NAFLD/NASH

Prof Bugianesi, Italy, reviews a burning issue: hepatocellular carcinoma (HCC) in patients...

Sep
22

NAFLD prevalence in Type 1 diabetes patients

The authors reviewed and screened references in order to estimate NAFLD prevalence...

Sep
22

Fatty liver index and risk of hypertension

The authors evaluated the ability of the fatty liver index to predict...

Sep
20

Emerging drugs targeting specific points in NASH pathogenesis

Extensive research and revelation in the field of pathogenesis of NASH has...

Sep
20

Review: NAFLD, driver of chronic kidney disease

This narrative review by C. D. Byrne and G. Targher provides an...

Sep
15

Children with suspected NAFLD: negative for other causes of liver disease

The authors aimed to determine the prevalence of alternative causes of liver...

The PanNASH initiative is supported by
logo (1)